- Report
- November 2025
- 184 Pages
Global
From €4058EUR$4,500USD£3,480GBP
- Report
- September 2026
- 195 Pages
Global
From €3197EUR$3,545USD£2,742GBP
€3552EUR$3,939USD£3,046GBP
- Report
- February 2026
- 250 Pages
Global
From €4049EUR$4,490USD£3,472GBP
- Report
- September 2026
- 416 Pages
Global
From €5276EUR$5,850USD£4,524GBP
- Report
- August 2026
- 150 Pages
Global
From €3382EUR$3,750USD£2,900GBP
- Report
- August 2026
- 160 Pages
Global
From €2994EUR$3,320USD£2,568GBP
€3743EUR$4,150USD£3,209GBP
- Report
- June 2026
- 53 Pages
Global
From €6764EUR$7,500USD£5,800GBP
- Report
- February 2026
- 491 Pages
Global
From €4464EUR$4,950USD£3,828GBP
- Report
- June 2026
- 200 Pages
Global
From €2696EUR$2,990USD£2,312GBP
- Report
- February 2026
- 200 Pages
Global
From €2696EUR$2,990USD£2,312GBP
- Report
- April 2026
- 200 Pages
Global
From €2696EUR$2,990USD£2,312GBP
- Report
- March 2026
- 100 Pages
Global
From €5366EUR$5,950USD£4,601GBP
- Report
- December 2025
- 150 Pages
Global
From €5366EUR$5,950USD£4,601GBP
- Report
- November 2025
- 250 Pages
Global
From €5366EUR$5,950USD£4,601GBP
- Report
- May 2026
- 142 Pages
Global
From €2705EUR$2,999USD£2,319GBP
€3606EUR$3,999USD£3,093GBP
- Report
- April 2026
- 147 Pages
Global
From €2705EUR$2,999USD£2,319GBP
€3606EUR$3,999USD£3,093GBP
- Report
- April 2026
- 140 Pages
Global
From €2705EUR$2,999USD£2,319GBP
€3606EUR$3,999USD£3,093GBP
- Report
- April 2026
- 139 Pages
Global
From €2705EUR$2,999USD£2,319GBP
€3606EUR$3,999USD£3,093GBP
- Report
- February 2026
- 135 Pages
Global
From €2705EUR$2,999USD£2,319GBP
€3606EUR$3,999USD£3,093GBP
- Report
- February 2026
- 250 Pages
Global
From €4049EUR$4,490USD£3,472GBP

The Implantable Cardioverter Defibrillator (ICD) market is a segment of the Cardiovascular Devices market. ICDs are medical devices used to treat life-threatening arrhythmias, or abnormal heart rhythms. They are implanted in the chest and monitor the heart's electrical activity. When an abnormal rhythm is detected, the device delivers an electrical shock to restore normal rhythm. ICDs are used to treat ventricular tachycardia and ventricular fibrillation, two of the most common causes of sudden cardiac death.
The ICD market is driven by the increasing prevalence of cardiovascular diseases, technological advancements, and the growing demand for minimally invasive treatments. The market is expected to grow at a steady rate over the forecast period.
Some of the major players in the ICD market include Medtronic, Abbott, Boston Scientific, Biotronik, LivaNova, and Sorin Group. Show Less Read more